Patents by Inventor Junhong ZHU

Junhong ZHU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220265712
    Abstract: Provided herein are methods of treating cancer in a human subject comprising administering to the subject an effective amount of CYNK cells to the subject so as thereby to provide an effective treatment of the cancer in the subject. The CYNK cells can be placental-derived natural killer (NK) cells or placental CD34+ cell-derived natural killer (NK) cells. The cancers to be treated include multiple myeloma and acute myeloid leukemia. The present invention also provides compositions comprising CYNK cells for the treatment of multiple myeloma and acute myeloid leukemia and methods of their use.
    Type: Application
    Filed: June 15, 2020
    Publication date: August 25, 2022
    Applicant: Celularity Inc.
    Inventors: Robert J. Hariri, Xiaokui Zhang, Nassir HABBOUBI, Catherine Balint, Erica Rave, Christopher Keller, Solveig Ericson, Sharmila Koppisetti, Stacy Herb, William van der Touw, Shuyang He, Junhong Zhu
  • Publication number: 20220000919
    Abstract: Provided herein are methods of using populations of natural killer (NK) cells and/or ILC3 cells derived from a population of hematopoietic stem or progenitor cells in methods for treating a viral infection, e.g., a coronavirus infection.
    Type: Application
    Filed: January 29, 2021
    Publication date: January 6, 2022
    Applicant: Celularity Inc.
    Inventors: Lin KANG, William VAN DER TOUW, Vanesssa VOSKINARIAN-BERSE, Xuan GUO, Robert J. HARIRI, Xiaokui ZHANG, Catherine BALINT, Nassir HABBOUBI, Stacy HERB, Sharmila KOPPISETTI, Tanel MAHLAKOIV, Bhavani STOUT, Junhong ZHU, Corey CASPER, Shuyang HE